We are live on ! Find out more
OFIX icon

Orthofix Medical

136 hedge funds and large institutions have $519M invested in Orthofix Medical in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

2% more capital invested

Capital invested by funds: $511M → $519M (+$7.96M)

7.54% less ownership

Funds ownership: 103.17%95.62% (-7.5%)

13% less funds holding

Funds holding: 156136 (-20)

20% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 55

47% less call options, than puts

Call options by funds: $40K | Put options by funds: $75K

69% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 26

Holders
136
Holders Change
-20
Holders Change %
-12.82%
% of All Funds
1.96%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
8
Increased
44
Reduced
55
Closed
26
Calls
$40K
Puts
$75K
Net Calls
-$35K
Net Calls Change
-$35K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Armistice Capital
New York
$53.7M +$1.38M +100,000 +3%
RCMNY
2
Rubric Capital Management (New York)
New York
$53.2M
BlackRock
3
BlackRock
New York
$47.8M -$333K -24,089 -0.7%
ECM
4
Engine Capital Management
New York
$44.1M
Morgan Stanley
5
Morgan Stanley
New York
$40.1M -$19.7M -1,426,041 -34%
Vanguard Group
6
Vanguard Group
Pennsylvania
$29.2M +$127K +9,150 +0.5%
PCMI
7
Paradigm Capital Management Inc
New York
$28.3M +$14M +1,010,663 +108%
NM
8
Newtyn Management
New York
$18.5M +$3.02M +218,153 +21%
State Street
9
State Street
Massachusetts
$15.5M -$1.34M -96,717 -8%
BCM
10
Boone Capital Management
Georgia
$14.1M +$6.56M +474,502 +95%
GCM
11
Glenview Capital Management
New York
$12.8M +$5.3M +383,125 +77%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$11.7M +$190K +13,775 +2%
EA
13
Emerald Advisers
Pennsylvania
$11.1M +$111K +8,018 +1%
ACA
14
AYAL Capital Advisors
Ontario, Canada
$9.05M +$2.04M +147,855 +31%
AIC
15
AWM Investment Company
New York
$6.89M
TC
16
Tejara Capital
United Kingdom
$6.31M +$562K +40,616 +10%
Millennium Management
17
Millennium Management
New York
$6.3M -$1.03M -74,360 -15%
EMFAT
18
Emerald Mutual Fund Advisers Trust
Pennsylvania
$5.73M
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$5.68M -$3.53M -255,053 -39%
Northern Trust
20
Northern Trust
Illinois
$5.13M -$26.2K -1,897 -0.5%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$4.98M -$1.6M -115,457 -25%
Charles Schwab
22
Charles Schwab
California
$4.12M -$2.46M -178,263 -39%
CC
23
Clearline Capital
New York
$3.76M -$856K -61,928 -19%
JAM
24
Jupiter Asset Management
United Kingdom
$3.74M -$546K -39,476 -13%
GLA
25
Great Lakes Advisors
Illinois
$3.28M -$63.8K -4,617 -2%

OFIX Hedge Fund Activity: Q1 2024 in Review

136 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q1 2024, worth a combined $519M — up 1.6% from $511M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of OFIX and 8 opened new positions — a net loss of 18 holders — while 55 trimmed existing stakes and 44 added.

The largest buyer was Paradigm Capital Management Inc, adding an estimated $14M. The largest seller was Morgan Stanley, cutting an estimated $19.7M.

  • 136 institutional investors held Orthofix Medical (OFIX) as of Q1 2024, down from 156 in Q4 2023.
  • Funds reported $519M of Orthofix Medical stock for Q1 2024, up 1.6% quarter-over-quarter.
  • 8 funds opened new Orthofix Medical positions in Q1 2024 and 26 closed out, a net change of -18 holders.
  • The largest Orthofix Medical buyer in Q1 2024 was Paradigm Capital Management Inc, an estimated $14M added.
  • The largest Orthofix Medical seller in Q1 2024 was Morgan Stanley, an estimated $19.7M sold.

Based on aggregated 13F filings for Q1 2024.